Clinical Trial Update: Efficacy of a Probiotic Lozenge (Inersan) in Patients With Chronic Periodontitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy of the probiotic lozenge Inersan for chronic periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Inersan

Snippet

Sponsor: CD Pharma India Pvt. Ltd. | Conditions: Chronic Periodontitis | Phase 3 | Status: COMPLETED